Obesity drugs could be included on WHO essential medicines list

Drugs that combat obesity could for the first time be included on the World Health Organisation's "essential medicines list," used to guide government purchasing decisions in low- and middle-income countries, the UN agency told a news agency. A panel of advisers to the WHO will review new requests for drugs to be included next month, with an updated essential medicines list due in September.

The request to consider obesity drugs was submitted by three doctors and a researcher in the United States. It covers the active ingredient liraglutide in Novo Nordisk's obesity drug Saxenda, which will come off patent soon, allowing for cheaper generic versions.

For more details, check out the link given below:

Obesity Drugs Could Be Added To WHO Essential Medicines List